Literature DB >> 16123992

Reversible posterior leukoencephalopathy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia.

Jennifer K Norman1, Julie T Parke, Don A Wilson, René Y McNall-Knapp.   

Abstract

We present three cases of children with acute neurologic changes while undergoing induction chemotherapy for acute lymphoblastic leukemia (ALL). These cases fall into the spectrum of reversible posterior leukoencephalopathy syndrome (RPLS), including abrupt alterations in mental status, headache, seizures, visual changes, hypertension, and characteristic findings on magnetic resonance imaging. Although the underlying mechanism of RPLS is still under investigation, the appropriate treatment and management of the acute event is becoming clearer. Early treatment of hypertension, control of seizure activity, and withdrawal of inciting agents can lead to rapid reversal of symptoms and return to baseline functioning.

Entities:  

Mesh:

Year:  2007        PMID: 16123992     DOI: 10.1002/pbc.20597

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  10 in total

1.  Posterior reversible encephalopathy syndrome in an adult patient with acute lymphoblastic leukemia after remission induction chemotherapy.

Authors:  Shokichi Tsukamoto; Masahiro Takeuchi; Chika Kawajiri; Satomi Tanaka; Yuhei Nagao; Yasumasa Sugita; Atsuko Yamazaki; Takeharu Kawaguchi; Tomoya Muto; Shio Sakai; Yusuke Takeda; Chikako Ohwada; Emiko Sakaida; Naomi Shimizu; Koutaro Yokote; Tohru Iseki; Chiaki Nakaseko
Journal:  Int J Hematol       Date:  2011-12-09       Impact factor: 2.490

Review 2.  Neurologic complications of antitumor antibody therapies.

Authors:  Teri N Kreisl
Journal:  Curr Neurol Neurosci Rep       Date:  2008-05       Impact factor: 5.081

3.  A Case of Pediatric Posterior Reversible Encephalopathy Syndrome (PRES) Secondary to Post-streptococcal Glomerulonephritis: A Literature Review and Assessment of Treatment Modalities.

Authors:  Abdurrahman F Kharbat; Pedro Calles; Allison Ogle; Tetyana L Vasylyeva; Kerrie Pinkney
Journal:  Cureus       Date:  2022-05-18

Review 4.  Reversible posterior leukoencephalopathy syndrome in childhood: report of nine cases and review of the literature.

Authors:  Hakan Gümüş; Hüseyin Per; Sefer Kumandaş; Ali Yikilmaz
Journal:  Neurol Sci       Date:  2009-10-07       Impact factor: 3.307

5.  Fatal outcome of posterior "reversible" encephalopathy syndrome in metastatic colorectal carcinoma after irinotecan and fluoropyrimidine chemotherapy regimen.

Authors:  Natalija Dedić Plavetić; Zoran Rakušić; David Ozretić; Luka Simetić; Ana Mišir Krpan; Vesna Bišof
Journal:  World J Surg Oncol       Date:  2014-08-20       Impact factor: 2.754

6.  Surgical treatment of refractory epilepsy after chemotherapy in two children with leukemia.

Authors:  Yun Leng; Tao Yu; Yongjie Li; Wenming Chen
Journal:  Epilepsy Behav Case Rep       Date:  2013-02-04

7.  Posterior reversible encephalopathy syndrome in pediatric patients undergoing treatment for hemophagocytic lymphohistiocytosis: clinical outcomes and putative risk factors.

Authors:  Goni Lee; Seung Eun Lee; Kyung-Ha Ryu; Eun Sun Yoo
Journal:  Blood Res       Date:  2013-12-24

Review 8.  Asparaginase-associated toxicity in children with acute lymphoblastic leukemia.

Authors:  Nobuko Hijiya; Inge M van der Sluis
Journal:  Leuk Lymphoma       Date:  2015-11-20

9.  PRES in the course of hemato-oncological treatment in children.

Authors:  Katarzyna Musioł; Sylwia Waz; Michał Boroń; Magdalena Kwiatek; Magdalena Machnikowska-Sokołowska; Katarzyna Gruszczyńska; Grażyna Sobol-Milejska
Journal:  Childs Nerv Syst       Date:  2017-12-02       Impact factor: 1.475

10.  Posterior Reversible Encephalopathy Syndrome in Pediatric Cancer: Clinical and Radiologic Findings.

Authors:  Saadiya Javed Khan; Arjumand Ali Arshad; Mohammad Bilal Fayyaz; Islah Ud Din Mirza
Journal:  J Glob Oncol       Date:  2017-12-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.